Why is the AUS Pharma & Biotech Research and Development May 2026 Report useful and how should I use it?

Why is the AUS Pharma & Biotech Research and Development May 2026 Report useful? Imagine being able to instantly see your competitors Market Share, Share of Spend and their top performing ad copy so you can effectively benchmark your own performance. Adthena’s PPC Market Share reports provide an instant view of performance insights across hundreds of sub-industries – so you can do just that. How to use the AUS Pharma & Biotech Research and Development May 2026 Report Think of these reports as a cheat sheet for your industry’s search landscape. Check out this short article for a breakdown of each report and how they can benefit your strategy.

How often is the data updated?

Data within the AUS Pharma & Biotech Research and Development May 2026 Report is aggregated every month, highlighting the most significant changes from the previous period.

How does Adthena collect this data?

We use observed data from Google’s search results pages. With 20 million Google SERPs indexed per day. Adthena forms a global index of publicly available searches on Google. On top of observed data, our data science models and patented technology expand on the insights through estimated metrics like market share, share of spend, and more. We have 12 years of historical data across industries and our custom-built AI models learn from continuously updated data every day.

How accurate is the AUS Pharma & Biotech Research and Development May 2026 Report?

The AUS Pharma & Biotech Research and Development May 2026 Report is powered by Adthena’s Whole Market View, which is the patented technology that drives value for our 300 enterprise customers. Our unique approach to search intelligence ingests Google’s Keyword Planner into its learning models, providing a more accurate and up-to-date view of keyword data compared to traditional panel data methods. With daily data collection and updates, Adthena offers a closer-to-real-time view of the Google Ads auction, enabling timely insights and adjustments. Adthena focuses specifically on Google Ads, providing a deep dive into the channel and offering detailed insights into its workings. By processing 10 TB of new data daily and employing AI and machine learning models to analyze millions of Google Ads searches per second, Adthena provides a comprehensive and in-depth view of the competitive landscape. Learn more about our data. Learn more about our data accuracy

Does this include mobile, desktop and Google Shopping data?

Yes. The AUS Pharma & Biotech Research and Development May 2026 Report aggregates data from across both device types and Google Shopping.

Who is this AUS Pharma & Biotech Research and Development May 2026 Report for?

The AUS Pharma & Biotech Research and Development May 2026 Report is for enterprise brands and agencies who want quick and high-level, historical benchmarks that are easily digestible and reveal insights, trends and market winners relevant to their own industry.

Ask Arlo leverages real-time GenAI to answer customers’ questions about their own search data and receive instant, tailored responses and reports directly within the Adthena platform. With millions of Google SERPs indexed every day, Arlo never misses a trick and makes sure you’re always up to date. Learn more about Ask Arlo.

AUS Pharma & Biotech Research and Development - PPC Market Share Analysis May 2026

Leveraging Adthena’s Whole Market View, this analysis explores recent trends in Google Ads for the AUS Research and Development category from the last month. Our Data Analyst, Ask Arlo provides commentary on key findings.

Google AI Overview visibility for Pharma & Biotech Research and Development AUS

See how often AIOs appear and how search intent is distributed across buying signals.

See more data

AIO Frequency

How often a Google AI overview appears on search terms relevant to this category.

Frequency	Percentage
Frequency	22.1116341627
	77.8883658373

22%

Complex Query Frequency

A complex query is a longer, more detailed search that often contains multiple keywords, specific conditions, or multi-part questions.

Frequency	Percentage
Frequency	8
	92

Search Intent Distribution

Breakdown of search queries by their underlying goal.

Intent	Distribution
Investigational	2%
Transactional	0%
Navigational	0%
Seasonal	0%
Local	0%
Problem Solving	4%

Market Exposure

Share of Clicks for top 10 AUS Pharma & Biotech Research and Development brands

Here are the Top 10 competitors in the industry by Share of Clicks for the last month.

See more data

Share of Clicks - Last month

Share of Clicks - Last month
Domain	Share of clicks
monash.edu	46.2
rmit.edu.au	12.61
unimelb.edu.au	11.39
uts.edu.au	7.84
uq.edu.au	6.35
hudson.org.au	3.43
hri.org.au	3.28
tri.edu.au	2.65
burnet.edu.au	2.01
sigmaaldrich.com	1.17
others	3.07

monash.edu - 46.2%
rmit.edu.au - 12.61%
unimelb.edu.au - 11.39%
uts.edu.au - 7.84%
uq.edu.au - 6.35%
hudson.org.au - 3.43%
hri.org.au - 3.28%
tri.edu.au - 2.65%
burnet.edu.au - 2.01%
sigmaaldrich.com - 1.17%
others - 3.07%

Monash.edu dominates with 46.2% click share, followed by rmit.edu.au at 12.61%. Unimelb.edu.au holds 11.39%, while others collectively capture 3.07%.

Market Exposure

Share of Spend for the top 10 AUS Pharma & Biotech Research and Development brands

Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.

See more data

Share of Spend - Last Month

Share of Spend - Last Month
Date	monash.edu	rmit.edu.au	uq.edu.au	unimelb.edu.au	hri.org.au	tri.edu.au	hudson.org.au	nucleusnetwork.com	uts.edu.au	burnet.edu.au
2026/05/01	0%	0%	0%	0%	30.41%	0%	19.25%	12.41%	0%	27.82%
2026/05/02	0%	0%	0%	0%	5.35%	0%	7.79%	4.29%	71.94%	7.23%
2026/05/03	0%	46.15%	0%	29.51%	6.18%	0%	5.62%	3.83%	0%	5.67%
2026/05/04	0%	74.67%	0%	0%	5.98%	0%	4.13%	7.82%	0%	4.45%
2026/05/05	17.17%	28.85%	26.5%	19.44%	3.05%	0%	0.85%	1.43%	0%	0.83%
2026/05/06	23.95%	0%	50.59%	15.48%	3.55%	0%	1.22%	2.05%	0%	1.18%
2026/05/07	46.23%	0%	0%	0%	3.01%	0%	1.35%	1.97%	43.55%	1.7%
2026/05/08	34.31%	42.49%	0%	0%	5.83%	2.63%	4.06%	2.93%	0%	4.48%
2026/05/09	56.94%	5.51%	0%	23.15%	1.52%	1.14%	0.43%	0.64%	9.6%	0.81%
2026/05/10	62.13%	29.01%	0%	4.34%	1.42%	0.64%	0.36%	0.63%	0%	0.96%
2026/05/11	61.67%	14.51%	0%	11.6%	3.23%	2.1%	0.53%	3.57%	0%	1.45%
2026/05/12	49.59%	13.79%	5.62%	19.3%	1.37%	1.46%	1.05%	0.22%	5.55%	0.69%
2026/05/13	46.43%	17.3%	0%	18.63%	1.42%	2.19%	1.57%	1.52%	8.33%	1.03%
2026/05/14	59.31%	25.53%	0%	9.4%	0.81%	1.39%	1.07%	0.87%	0%	0.72%
2026/05/15	66.28%	8.7%	0%	15.65%	1.19%	2.52%	1.81%	1.28%	0%	0.67%
2026/05/16	67.44%	6.95%	0%	6.95%	1.32%	1.12%	2.06%	1.02%	11.2%	0.4%
2026/05/17	79.52%	0%	0%	0%	2.48%	1.3%	2.34%	1.02%	11.2%	0.6%
2026/05/18	37.43%	17.86%	21.85%	12.03%	0.71%	0.97%	1.96%	0.98%	0%	0.39%
2026/05/19	43%	42.48%	0%	0%	1.7%	2.72%	4.13%	1.83%	0%	1.38%
2026/05/20	34.74%	43.02%	0%	0%	3.5%	3.38%	4.2%	2.96%	0%	3.73%
2026/05/21	56.95%	17.6%	0%	16.85%	2%	1.38%	2.46%	0%	0%	1.22%
2026/05/22	57.82%	16.44%	0%	17.7%	2.1%	0.53%	1.49%	0%	0%	1.43%
2026/05/23	51.91%	5.12%	0%	18.43%	0.55%	0.14%	0.68%	0%	21.29%	0.8%
2026/05/24	75.39%	0%	6.96%	6.83%	0.46%	0.49%	0.31%	0%	6.88%	0.84%
2026/05/25	66.35%	0%	19.41%	9.47%	0.28%	0.68%	0.79%	0%	0%	0.48%
2026/05/26	71.07%	9.56%	0%	0%	0%	0.55%	0.99%	0%	15.4%	0.39%
2026/05/27	51.06%	14.6%	5.95%	13.13%	0%	0.42%	0.76%	0%	11.75%	0.29%
2026/05/28	58.5%	0%	0%	17.71%	0%	0.21%	0.38%	0%	21.95%	0.08%
2026/05/29	36.34%	19.19%	18.63%	18.28%	0%	1.32%	1.28%	0.74%	0%	0.26%
2026/05/30	30.06%	37.22%	0%	25.24%	1.3%	0.43%	0.42%	0.24%	0%	0.08%
2026/05/31	41.01%	34.86%	12.44%	6.07%	1.57%	0.44%	0.43%	0.25%	0%	0%

monash.edu
rmit.edu.au
uq.edu.au
unimelb.edu.au
hri.org.au
tri.edu.au
hudson.org.au
nucleusnetwork.com
uts.edu.au
burnet.edu.au

Monash.edu’s PPC spend surged in May, peaking at 79.52 on the 17th. RMIT.edu.au fluctuated, starting strong but dipping mid-month. UTS.edu.au and UQ.edu.au showed sporadic activity. By month’s end, Monash.edu led, with others trailing.

Market Exposure

Competitor Count for AUS Pharma & Biotech Research and Development

Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.

See more data

Competitor Count - Last month

Competitor Count - Last month
Date	Competitor Count
2026/05/01	6
2026/05/02	7
2026/05/03	8
2026/05/04	7
2026/05/05	10
2026/05/06	9
2026/05/07	8
2026/05/08	9
2026/05/09	10
2026/05/10	9
2026/05/11	10
2026/05/12	12
2026/05/13	12
2026/05/14	11
2026/05/15	11
2026/05/16	12
2026/05/17	10
2026/05/18	12
2026/05/19	9
2026/05/20	9
2026/05/21	9
2026/05/22	9
2026/05/23	9
2026/05/24	9
2026/05/25	8
2026/05/26	7
2026/05/27	11
2026/05/28	9
2026/05/29	11
2026/05/30	11
2026/05/31	10

May began with 6 advertisers, peaking at 12 mid-month. The month concluded with 10 advertisers, reflecting dynamic competition.

Campaign Efficiency

Market Loss & Market Gains for AUS Pharma & Biotech Research and Development

Here we’re looking at the Top 10 biggest industry movers by market share gains and losses for the last 30 days.

See more data

Market Loss & Market Gains - Last month

Market Loss & Market Gains - Last month
Name	Market Trend
sigmaaldrich.com	2.37%
uq.edu.au	1.67%
uts.edu.au	1.48%
unimelb.edu.au	0.9%
naturecareers.com	0.88%
rmit.edu.au	-0.46%
burnet.edu.au	-1%
nucleusnetwork.com	-1.1%
hri.org.au	-1.23%
monash.edu	-5.25%

Sigmaaldrich.com surged with a 2.37% click share increase, while monash.edu faced a significant drop of 5.25%.

Campaign Efficiency

AUS Pharma & Biotech Research and Development Share of Impressions

Take a look at the Top 10 competitors in the industry by Share of Impressions over the last month.

See more data

Date	monash.edu	rmit.edu.au	uq.edu.au	unimelb.edu.au	tri.edu.au	hri.org.au	hudson.org.au	uts.edu.au	sigmaaldrich.com	burnet.edu.au
2026/05/01	0%	0%	0%	0%	0%	34.01%	29.55%	0%	0%	18.22%
2026/05/02	0%	0%	0%	0%	0%	9.28%	12.78%	59.38%	0%	9.28%
2026/05/03	0%	32.74%	0%	26.79%	0%	9.95%	11.07%	0%	0%	11.07%
2026/05/04	0%	61.92%	0%	0%	0%	9.41%	7.48%	0%	0%	8.97%
2026/05/05	13.79%	22.57%	22.57%	22.57%	0%	8.58%	2%	0%	0%	2.66%
2026/05/06	18.5%	0%	45.4%	15.13%	0%	8.57%	2.68%	0%	0%	3.57%
2026/05/07	32%	0%	0%	0%	0%	5.94%	2.83%	48%	0%	5.67%
2026/05/08	24.68%	24.68%	0%	0%	2.91%	13.97%	12.08%	0%	0%	13.11%
2026/05/09	44.75%	5.67%	0%	28.36%	1.34%	3.55%	1%	11.35%	0%	2.68%
2026/05/10	56.13%	25.91%	0%	6.48%	1.64%	3.4%	1.15%	0%	0%	3.44%
2026/05/11	23.84%	7.4%	0%	7.4%	2.31%	3.44%	0.87%	0%	49.16%	2.18%
2026/05/12	38.34%	14.08%	7.04%	21.12%	3.57%	2.32%	2.2%	7.04%	0%	2.08%
2026/05/13	37.86%	10.99%	0%	21.98%	5.57%	1.49%	3.44%	10.99%	0%	3.24%
2026/05/14	52.67%	20.61%	0%	13.74%	3.89%	0.93%	2.55%	0%	0%	2.84%
2026/05/15	53.72%	9.12%	0%	18.25%	6.94%	1.24%	4.62%	0%	0%	1.62%
2026/05/16	52.94%	7.33%	0%	7.33%	4.28%	2.42%	6.57%	14.66%	0%	0.87%
2026/05/17	50.92%	0%	0%	0%	3.77%	3.08%	6.96%	11.75%	0%	20.62%
2026/05/18	24.95%	11.82%	17.73%	11.82%	2.65%	2.3%	5.85%	0%	19.63%	0.7%
2026/05/19	32.12%	32.12%	0%	0%	8.14%	6.25%	12.49%	0%	0%	2.84%
2026/05/20	23.76%	23.76%	0%	0%	10.64%	10.64%	15.26%	0%	0%	7.01%
2026/05/21	42%	10.5%	0%	21%	4.7%	6.74%	10.21%	0%	0%	2.48%
2026/05/22	45.39%	10.21%	0%	20.43%	2.77%	7.94%	6.56%	0%	0%	3.01%
2026/05/23	39.52%	5.15%	0%	20.62%	0.7%	2%	3.01%	25.77%	0%	1.83%
2026/05/24	61.2%	0%	9.18%	9.18%	3.73%	1.79%	1.08%	9.18%	0%	2.17%
2026/05/25	57.6%	0%	13.64%	13.64%	5.54%	1.85%	2.42%	0%	0%	1.61%
2026/05/26	58.08%	10.25%	0%	0%	4.16%	0%	3.02%	20.5%	0%	1.21%
2026/05/27	38.79%	14.86%	7.43%	14.86%	3.02%	0%	2.19%	14.86%	0%	0.88%
2026/05/28	45.21%	0%	0%	21.05%	1.9%	0%	1.36%	28.06%	0%	0.41%
2026/05/29	22.43%	22.43%	18.36%	18.36%	7.46%	0%	3.57%	0%	0%	1.08%
2026/05/30	23.93%	23.93%	0%	31.9%	3.24%	1.55%	1.55%	0%	0%	0.47%
2026/05/31	37.96%	30.58%	9.49%	9.49%	3.86%	2.41%	1.85%	0%	0%	0%

monash.edu
rmit.edu.au
uq.edu.au
unimelb.edu.au
tri.edu.au
hri.org.au
hudson.org.au
uts.edu.au
sigmaaldrich.com
burnet.edu.au

Monash.edu’s impression share surged mid-month, peaking at 61.2% on May 24. RMIT.edu.au fluctuated, ending at 30.58%. UTS.edu.au saw a high of 59.38% early on. Sigmaaldrich.com and UQ.edu.au had modest shares. Unimelb.edu.au and TRI.edu.au remained steady, while HRI.org.au and Hudson.org.au showed minor variations. Burnet.edu.au’s share was minimal.

Campaign Efficiency

Google Text Ad Copy Insights & Creative Trends for AUS Pharma & Biotech Research and Development

Ever wondered how your rivals’ ads are doing? Here we can see the top-performing ads in the industry over the last month.

See more data

Google Text Ad Copy Insights & Creative Trends for AUS Pharma & Biotech Research and Development - Last month

1
Pharmaceutical Science https://www.monash.edu › pharm-sci › postgraduate
Study Pharm Sci at Monash — Preparing students with advanced knowledge and skills needed for a pharmaceutical career. Study at a Top Global University for Pharmacy and Pharmacology. Apply For Monash Today. Industry Leaders.
2
Study Science At RMIT - Biotechnology & Biological Sc https://www.rmit.edu.au
Explore The Latest In Biotechnology & Biological Sciences At RMIT. Develop Skills & Knowledge To Advance Your Career In Biotechnology & Biological...
3
Master of Biotechnology - The University of Melbourne https://study.unimelb.edu.au › grad_science › specialist
Biotechnology is a key 21st-century industry with strong, growing demand for specialists. Gain real-work experience, work with industry partners to solve biotech-related problems.
4
UQ Master Of Biotechnology https://study.uq.edu.au › master › biotechnology
The University Of Queensland — Wherever Your Future Lies, Get There Faster With UQ's Master Of Biotechnology. Reach Your Full...
5
Medical Biotechnology Masters https://www.uts.edu.au
Study with UTS Science — Harness the power of biological science and engineering to transform human health. Pursue your postgraduate studies with a course at UTS Science. Integrated Learning. Enrol online.

In the competitive landscape of pharmaceutical and biotech education, Monash University stands out with its focus on advanced pharmaceutical science, while RMIT and UQ emphasize biotechnology’s evolving role. The University of Melbourne and UTS highlight real-world experience and transformative health solutions, respectively.

Frequently Asked Questions

Why is the AUS Pharma & Biotech Research and Development May 2026 Report useful and how should I use it?

Why is the AUS Pharma & Biotech Research and Development May 2026 Report useful?

Imagine being able to instantly see your competitors Market Share, Share of Spend and their top performing ad copy so you can effectively benchmark your own performance.

Adthena’s PPC Market Share reports provide an instant view of performance insights across hundreds of sub-industries – so you can do just that.

How to use the AUS Pharma & Biotech Research and Development May 2026 Report
Think of these reports as a cheat sheet for your industry’s search landscape. Check out this short article for a breakdown of each report and how they can benefit your strategy.
How often is the data updated?

Data within the AUS Pharma & Biotech Research and Development May 2026 Report is aggregated every month, highlighting the most significant changes from the previous period.
How does Adthena collect this data?

We use observed data from Google’s search results pages. With 20 million Google SERPs indexed per day. Adthena forms a global index of publicly available searches on Google.

On top of observed data, our data science models and patented technology expand on the insights through estimated metrics like market share, share of spend, and more.

We have 12 years of historical data across industries and our custom-built AI models learn from continuously updated data every day.
How accurate is the AUS Pharma & Biotech Research and Development May 2026 Report?

The AUS Pharma & Biotech Research and Development May 2026 Report is powered by Adthena’s Whole Market View, which is the patented technology that drives value for our 300 enterprise customers.

Our unique approach to search intelligence ingests Google’s Keyword Planner into its learning models, providing a more accurate and up-to-date view of keyword data compared to traditional panel data methods.

With daily data collection and updates, Adthena offers a closer-to-real-time view of the Google Ads auction, enabling timely insights and adjustments.

Adthena focuses specifically on Google Ads, providing a deep dive into the channel and offering detailed insights into its workings. By processing 10 TB of new data daily and employing AI and machine learning models to analyze millions of Google Ads searches per second, Adthena provides a comprehensive and in-depth view of the competitive landscape.

Learn more about our data.

Learn more about our data accuracy
Does this include mobile, desktop and Google Shopping data?

Yes. The AUS Pharma & Biotech Research and Development May 2026 Report aggregates data from across both device types and Google Shopping.
Who is this AUS Pharma & Biotech Research and Development May 2026 Report for?

The AUS Pharma & Biotech Research and Development May 2026 Report is for enterprise brands and agencies who want quick and high-level, historical benchmarks that are easily digestible and reveal insights, trends and market winners relevant to their own industry.
Can I get a custom report for my brand?

Our search consultants can introduce you to data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the geographies that need monitoring.

Complete the form below to get started.
What is Ask Arlo?

Ask Arlo leverages real-time GenAI to answer customers’ questions about their own search data and receive instant, tailored responses and reports directly within the Adthena platform.

With millions of Google SERPs indexed every day, Arlo never misses a trick and makes sure you’re always up to date.

Learn more about Ask Arlo.

Customer Success Stories

the7stars achieves Google Ads PPC campaign optimization with Adthena

Leveraging Adthena's comprehensive insights, the7stars and their lottery client optimized their PPC campaigns and organic strategies, resulting in substantial cost savings and improved campaign performance. Read case study

Sage case study: 75% decrease in CPCs with Adthena

Sage, a leading UK software provider, used Adthena’s brand protection strategy to curb rising CPC costs. By identifying brand infringements and optimizing spend, they effectively strengthened their brand protection strategy and increased ROI.Read case study

Vodafone case study: Driving click share and sales with strategic insights from Adthena

Vodafone used Adthena data to optimize results from the launch of the Samsung S22 product. Combining Adthena’s Strategic Insights with Google Smart Bidding, Vodafone was able to maintain a flexible strategy that leveraged both manual and automated bidding. Leveraging Adthena’s Search Term Opportunities report also allowed Vodafone to implement 27 keyword terms across their business line, driving an increase in revenue at a positive ROAS.Read case study

Get the full picture

See this data specific to your brand performance

The data on this page is just a sample of the billions of data points we hold at Adthena. The insights generated by Ask Arlo, leverage real-time GenAI to answer questions about your search data.

Our search consultants can introduce you to Whole Market View data that is specific to your organization, based on the size of the relevant search term and competitor universe, and the locations that you need monitoring.

AUS Pharma & Biotech Research and Development - PPC Market Share Analysis May 2026